ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,613Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 1802

$544K Total Retail Price of All Prescriptions

Rank: 74 out of 1802

332 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 332 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 332 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,527 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
FUROSEMIDE 573 521 1 5
LISINOPRIL 513 468 2 3
LEVOTHYROXINE SODIUM 446 423 3 2
SIMVASTATIN 401 315 4 1
WARFARIN SODIUM 367 327 5 7
OMEPRAZOLE 324 298 6 4
AMLODIPINE BESYLATE 266 229 7 6
SERTRALINE HCL 262 249 8 20
METOPROLOL TARTRATE 258 235 9 9
FENTANYL 257 247 S2 10 43
METFORMIN HCL 236 171 11 11
DONEPEZIL HCL 218 213 12 26
HYDROCHLOROTHIAZIDE 210 198 13 8
NAMENDA 203 203 14 34
POTASSIUM CHLORIDE 175 149 15 15
MELOXICAM 167 155 16 59
CITALOPRAM HBR 160 147 17 17
ATORVASTATIN CALCIUM 158 151 18 14
HYDROCODONE-ACETAMINOPHEN 156 153 S3 19 10
POLYETHYLENE GLYCOL 3350 145 125 20 29
ALENDRONATE SODIUM 141 141 21 21
ATENOLOL 135 123 22 12
GLYBURIDE 122 104 R 23 68
ZETIA 119 107 24 79
TRAMADOL HCL 110 101 25 22
METOPROLOL SUCCINATE 109 108 26 13
CARVEDILOL 104 80 27 36
ALLOPURINOL 101 101 28 24
LOSARTAN POTASSIUM 93 93 29 18
DIGOXIN 92 92 30 45
MIRTAZAPINE 91 91 31 38
TAMSULOSIN HCL 86 86 32 28
OXYCODONE HCL 84 82 S2 33 41
DIOVAN 83 83 34 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 81 35 23
EXELON 81 81 35 170
LANTUS 78 67 37 47
RISPERIDONE 77 77 38 64
PREDNISONE 73 72 39 33
CARBIDOPA-LEVODOPA 72 68 40 70
OXYBUTYNIN CHLORIDE 72 60 40 87
TRAZODONE HCL 70 70 42 39
CLONIDINE HCL 69 63 43 77
PRAVASTATIN SODIUM 66 65 44 19
TRIAMCINOLONE ACETONIDE 65 58 45 91
GABAPENTIN 64 64 46 16
NIASPAN 63 52 47 78
NEXIUM 61 45 48 50
LOVASTATIN 59 47 49 25
FINASTERIDE 58 58 50 88
ADVAIR DISKUS 58 50 50 32
GEMFIBROZIL 56 38 52 83
PROAIR HFA 55 52 53 58
LAMOTRIGINE 54 0 54 114
CLOPIDOGREL 54 54 54 48
TERAZOSIN HCL 51 51 56 90
QUETIAPINE FUMARATE 50 50 57 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.